Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1906 1
1930 2
1931 2
1950 1
1951 2
1952 1
1953 1
1954 2
1955 1
1956 1
1958 1
1962 1
1963 4
1964 2
1965 6
1966 5
1967 2
1968 6
1969 12
1970 9
1971 14
1972 7
1973 11
1974 12
1975 10
1976 13
1977 14
1978 13
1979 24
1980 41
1981 20
1982 22
1983 19
1984 22
1985 29
1986 23
1987 35
1988 34
1989 37
1990 32
1991 33
1992 26
1993 19
1994 27
1995 33
1996 27
1997 25
1998 30
1999 27
2000 28
2001 34
2002 31
2003 30
2004 34
2005 58
2006 47
2007 60
2008 62
2009 76
2010 92
2011 119
2012 137
2013 134
2014 128
2015 116
2016 130
2017 136
2018 143
2019 152
2020 170
2021 180
2022 207
2023 189
2024 97

Text availability

Article attribute

Article type

Publication date

Search Results

3,054 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer.
Nixon BG, Kuo F, Ji L, Liu M, Capistrano K, Do M, Franklin RA, Wu X, Kansler ER, Srivastava RM, Purohit TA, Sanchez A, Vuong L, Krishna C, Wang X, Morse Iii HC, Hsieh JJ, Chan TA, Murphy KM, Moon JJ, Hakimi AA, Li MO. Nixon BG, et al. Among authors: srivastava rm. Immunity. 2022 Nov 8;55(11):2044-2058.e5. doi: 10.1016/j.immuni.2022.10.002. Epub 2022 Oct 25. Immunity. 2022. PMID: 36288724 Free PMC article.
Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.
Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M, Wu M, Wu F, Zhou F, Du Y, Chai RC, Zhang W, Qiu X, Liu Q, Wang Z, Li J, Li K, Chen A, Jiang Y, Xiao X, Zou H, Srivastava R, Zhang T, Cai Y, Liang Y, Huang B, Zhang R, Lin F, Hu L, Wang X, Qian X, Lv S, Hu B, Zheng S, Hu Z, Shen H, You Y, Verhaak RGW, Jiang T, Wang Q. Wu L, et al. Among authors: srivastava r. Cancer Discov. 2022 Dec 2;12(12):2820-2837. doi: 10.1158/2159-8290.CD-22-0196. Cancer Discov. 2022. PMID: 36122307 Free PMC article.
Home Help.
Srivastava R. Srivastava R. N Engl J Med. 2022 Feb 17;386(7):614-615. doi: 10.1056/NEJMp2112785. Epub 2022 Feb 12. N Engl J Med. 2022. PMID: 35148037 No abstract available.
Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis.
Do MH, Shi W, Ji L, Ladewig E, Zhang X, Srivastava RM, Capistrano KJ, Edwards C, Malik I, Nixon BG, Stamatiades EG, Liu M, Li S, Li P, Chou C, Xu K, Hsu TW, Wang X, Chan TA, Leslie CS, Li MO. Do MH, et al. Among authors: srivastava rm. Immunity. 2023 Nov 14;56(11):2555-2569.e5. doi: 10.1016/j.immuni.2023.10.010. Immunity. 2023. PMID: 37967531
Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination.
Kapell H, Fazio L, Dyckow J, Schwarz S, Cruz-Herranz A, Mayer C, Campos J, D'Este E, Möbius W, Cordano C, Pröbstel AK, Gharagozloo M, Zulji A, Narayanan Naik V, Delank A, Cerina M, Müntefering T, Lerma-Martin C, Sonner JK, Sin JH, Disse P, Rychlik N, Sabeur K, Chavali M, Srivastava R, Heidenreich M, Fitzgerald KC, Seebohm G, Stadelmann C, Hemmer B, Platten M, Jentsch TJ, Engelhardt M, Budde T, Nave KA, Calabresi PA, Friese MA, Green AJ, Acuna C, Rowitch DH, Meuth SG, Schirmer L. Kapell H, et al. Among authors: srivastava r. J Clin Invest. 2023 Apr 3;133(7):e164223. doi: 10.1172/JCI164223. J Clin Invest. 2023. PMID: 36719741 Free PMC article.
Why I Write.
Srivastava R. Srivastava R. Acad Med. 2023 Jun 1;98(6S):S28-S29. doi: 10.1097/ACM.0000000000005177. Epub 2023 May 23. Acad Med. 2023. PMID: 36811975
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Vos JL, Burman B, Jain S, Fitzgerald CWR, Sherman EJ, Dunn LA, Fetten JV, Michel LS, Kriplani A, Ng KK, Eng J, Tchekmedyian V, Haque S, Katabi N, Kuo F, Han CY, Nadeem Z, Yang W, Makarov V, Srivastava RM, Ostrovnaya I, Prasad M, Zuur CL, Riaz N, Pfister DG, Klebanoff CA, Chan TA, Ho AL, Morris LGT. Vos JL, et al. Among authors: srivastava rm. Nat Med. 2023 Dec;29(12):3077-3089. doi: 10.1038/s41591-023-02518-x. Epub 2023 Aug 24. Nat Med. 2023. PMID: 37620627 Clinical Trial.
Editorial: Recent Advances in Basic and Translational Osteoimmunology.
Srivastava RK, Schmidt-Bleek K, Chattopadhyay N, De Martinis M, Mishra PK. Srivastava RK, et al. Front Immunol. 2021 Nov 18;12:800508. doi: 10.3389/fimmu.2021.800508. eCollection 2021. Front Immunol. 2021. PMID: 34868088 Free PMC article. No abstract available.
3,054 results